TABLE 3.
Mpro cleavage site no. | P2 residue for:
|
|||
---|---|---|---|---|
SARS-CoV | HCoV-HKU1 | IBV | TGEV | |
1 | L | L | L | L |
2 | F | L | L | N |
3 | V | I | M | V |
4 | L | L | L | L |
5 | L | M | L | L |
6 | L | L | L | L |
7 | M | V | V | M |
8 | L | M | L | L |
9 | L | L | L | L |
10 | L | L | L | L |
11 | L | M | L | L |